NICE guidance on aflibercept for treatment of metastatic colorectal cancer

被引：0
|
作者：
Elsada, Ahmed [1 ]
George, Elisabeth [1 ]
Adler, Amanda [1 ]
机构：
[1] Natl Inst Hlth & Care Excellence, Manchester M1 4BT, Lancs, England
来源：
LANCET ONCOLOGY | 2014年 / 15卷 / 06期
关键词：
D O I：
10.1016/S1470-2045(14)70133-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：561 / 562
页数：2
相关论文
共 50 条
  • [31] NICE issues guidance for diagnosis and treatment of lung cancer
    Mayor, S
    BRITISH MEDICAL JOURNAL, 2005, 330 (7489): : 439 - 439
  • [32] Bevacizumab for Metastatic Colorectal Cancer A NICE Single Technology Appraisal
    Whyte, Sophie
    Pandor, Abdullah
    Stevenson, Matt
    PHARMACOECONOMICS, 2012, 30 (12) : 1119 - 1132
  • [33] Targeting Angiogenesis and Tumor Microenvironment in Metastatic Colorectal Cancer: Role of Aflibercept
    Giordano, Guido
    Febbraro, Antonio
    Venditti, Michele
    Campidoglio, Serena
    Olivieri, Nunzio
    Raieta, Katia
    Parcesepe, Pietro
    Imbriani, Giusy Carmen
    Remo, Andrea
    Pancione, Massimo
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2014, 2014
  • [34] US FDA approves ziv-aflibercept for metastatic colorectal cancer
    不详
    COLORECTAL CANCER, 2012, 1 (05) : 363 - 364
  • [35] US FDA approves ziv-aflibercept for metastatic colorectal cancer
    Williamson, Ruth
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (10) : 1249 - 1249
  • [36] Reply 1: Call for NICE to review urgently their guidance concerning first-line chemotherapy for metastatic colorectal cancer
    M P Saunders
    J W Valle
    British Journal of Cancer, 2003, 88 : 1153 - 1154
  • [37] Reply 1: Call for NICE to review urgently their guidance concerning first-line chemotherapy for metastatic colorectal cancer
    Saunders, MP
    Valle, JW
    BRITISH JOURNAL OF CANCER, 2003, 88 (07) : 1153 - 1154
  • [38] COST EFFECTIVENESS OF CETUXIMAB IN FIRST LINE TREATMENT OF METASTATIC COLORECTAL CANCER: DESCRIPTION OF A NICE SUBMISSION
    Eggington, S. G.
    Garrell, D.
    Griebsch, I
    Samyshkin, Y.
    VALUE IN HEALTH, 2009, 12 (07) : A279 - A279
  • [39] Pharmacokinetic and pharmacodynamic evaluation of aflibercept for the treatment of colorectal cancer
    Sanz-Garcia, Enrique
    Sauri, Tamara
    Tabernero, Josep
    Macarulla, Teresa
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (06) : 995 - 1004
  • [40] Erratum to: Aflibercept, a New Way to Target Angiogenesis in the Second Line Treatment of Metastatic Colorectal Cancer (mCRC)
    Mario Scartozzi
    Loic Vincent
    Marielle Chiron
    Stefano Cascinu
    Targeted Oncology, 2017, 12 : 123 - 123
12345